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Mutations in the collagen XVII gene, COL17A1, are associated with junctional epidermolysis bullosa. Most COL17A1
mutations lead to a premature termination codon (PTC), whereas only a few mutations result in amino acid sub-
stitutions or deletions. We describe here two novel glycine substitutions, G609D and G612R, and a splice site
mutation resulting in a deletion of three Gly–X–Y amino acid triplets. In order to investigate the molecular patho-
mechanisms of non-PTC mutations, G609D and G612R and two previously known substitutions, G627V and G633,
and deletion of the amino acids 779–787 were introduced into recombinant collagen XVII. The thermal stability of
the mutated collagens was assessed using trypsin digestions at incremental temperatures. All the four glycine
substitutions significantly destabilized the ectodomain of collagen XVII, which manifested as 161C–201C lower Tm
(midpoint of the helix-to-coil transition). These results were supported by secondary structure predictions, which
suggested interruptions of the collagenous triple helix within the largest collagenous domain, Col15. In contrast,
deletion of the three full Gly–X–Y triplets, amino acids 779–787, had no overall effect on the stability of the
ectodomain, as the deletion was in register with the triplet structure and also generated compensatory changes in
the NC15 domain.
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Collagen XVII belongs to the family of collagenous trans-
membrane proteins, which share a number of structural
features and are involved in a broad spectrum of biological
functions, ranging from cell adhesion to immunological de-
fence (for a review, see Franzke et al, 2005). Collagen XVII,
also referred to as the 180-kDa bullous pemphigoid antigen
or BP180, is a structural component of hemidesmosomes,
i.e., multiprotein complexes that anchor epithelial cells,
such as the basal keratinocytes, to the underlying basement
membrane (Borradori and Sonnenberg, 1999). The molecule
has a type II orientation in the plasma membrane and it is
involved in multiple intra- and extracellular protein–protein
interactions (Giudice et al, 1992; Scha¨cke et al, 1998; Ta-
sanen et al, 2000a, 2004, see Van den Bergh and Giudice,
2003). The globular intracellular domain resides in the cy-
toplasmic plaque of hemidesmosomes, and the large, ex-
tracellular collagenous domain is located in the region of
anchoring filaments in the basement membrane. The ecto-
domain has significant thermal stability and is proteolytically
released from the cell surface by ADAMs (a disintegrin and
metalloproteinase; Tasanen et al, 2000a; Areida et al, 2001;
Franzke et al, 2002, 2004).
Junctional epidermolysis bullosa (JEB) consists of a
group of autosomal recessive bullous disorders caused by
mutations in the genes for laminin 5, a6b4 integrin, and
collagen XVII (Fine et al, 2000; Bruckner-Tuderman, 2002).
Characteristic morphological abnormalities caused by mu-
tations in COL17A1 include rudimentary hemidesmosomes
and separation of the basal keratinocyte from the underlying
basement membrane (Fine et al, 2000; Bauer and Lan-
schuetzer, 2003). The majority of COL17A1 defects are non-
sense mutations, or small insertions or deletions. They re-
sult in a premature termination codon (PTC), absence of
collagen XVII in the skin and phenotypic features, such as
generalized, life-long blistering of skin and mucous mem-
branes, skin atrophy, total alopecia, nail dystrophy, and
dental abnormalities (McGrath et al, 1995; Floeth et al, 1998;
Pulkkinen et al, 2002 and references therein). In contrast,
missense mutations or amino acid deletions are more rare
(see Bauer and Lanschuetzer, 2003; Van den Bergh and
Giudice, 2003). The mutations G627V (McGrath et al, 1996)
and G633D (Tasanen et al, 2000b) and an in-frame deletion
of the amino acids 779–787 (Chavanas et al, 1997) affect the
largest collagenous domain, Col15, of collagen XVII and
cause skin fragility and dystrophies in nails and teeth.
We describe two new glycine substitutions, G609D and
G612R, which also target the Col15 domain of collagen
XVII. In addition, we report a novel carrier of the in-frame
Abbreviations: D779–787, deletion of amino acids 779–787; JEB,
junctional epidermolysis bullosa; NC, non-collagenous sequence;
PTC, premature termination codon
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deletion of the amino acids 779–787. To investigate the
consequences of these non-PTC mutations at the molecular
level, we used recombinant expression of full-length colla-
gen XVII and analyzed the effects of the mutations on the
thermal stability of the ectodomain.
Results
Identiﬁcation and veriﬁcation of mutations Patient 1 (Fig
1A) was known to be compound heterozygous for a
c.3781C4T transition, but his maternal mutation remained
unknown (Floeth et al, 1998). Repeated mutation screening
revealed the second mutation, a c.1826G4A transition,
which results in a Gly to Asp substitution at the amino acid
position 609 and was designated as p.G609D. Verification
by ItaI endonuclease digestion showed that the patient and
his mother were heterozygous for this mutation (Fig 1A). By
restriction digestion with ItaI, this sequence variant could
not be identified in 100 control alleles. Patient 2 (Fig 1B)
was homozygous for a transition c.1834G4A, which caus-
es a Gly to Arg substitution at the amino acid position 612
and was designated as p.G612R. This sequence variant
was not identified in 100 control alleles. Automated
Figure 1
Pedigrees and mutations in the COL17A1 gene. Pedigrees demonstrate recessive inheritance of the mutations. (A) Family 1: patient 1 was a
compound heterozygous for the mutations c.3781C ! T (striped areas) and c.1826G4A (black areas). Restriction digestion with ItaI shows in the
sister (2) and the father (4) 143, 125, and 107 bp bands corresponding to the wild-type allele (C). The patient (1) and his mother (3) show 268, 143,
125, and 107 bp bands corresponding to their heterozygous states. The generalized mild blistering and toenail dystrophy of the proband are also
illustrated. (B) Family 2: patient 2 (1) was homozygous for the transition c.1834G4A in exon 22 (black areas). The mutation was present in a
heterozygous state in both the mother and the father, but was absent from the controls. (C) Family 3: patients 3 (1) and 4 (2) were heterozygous for a
duplication of C at the position 3800 in exon 52 (striped areas) and the mutation at the position c.1834G4A, at the last exonic position before intron
22 (black areas). To verify if the transition c.1834G4A disturbs normal splicing, RT-PCR with total RNA extracted from keratinocytes of patient 3 was
performed using the exonic primer spanning the exons 17–23. Direct sequencing indicated normal splicing and homozygocity for c.1834G4A (not
shown). These findings show that c.1834G4A is a missense mutation changing the codon 612 GGA to AGA (p.G612R), and that the frameshift
mutation in exon 52 leads to nonsense-mediated RNA decay. The mother (3) was heterozygous for the c.1834 G4A transition and the father (4) for
c.3800dupC. The dental abnormalities, toenail dystrophy, and a poorly healing wound area on the scalp of patient 3 are also shown. (D) Patient 5
was homozygous for a splice site mutation c.2336-2A4G (black areas), which results in in-frame skipping of the entire exon 32. This mutation was
absent from the control, but the mother (2) and the father (3) were both heterozygous. A restriction site for PstI was eliminated by the mutation
c.2336-2A4G. The 347 bp normal control PCR product was cleaved into 106 bp (middle band), 78, 75, 69, and 19 bp products (not separated, can
be seen as a lower band). The digestions of amplimers of the proband (1), the mother (2), and the father (3) resulted in an additional uncleaved 175
bp product (upper band), which reflects the loss of the PstI restriction site because of an A to G mutation. The acral blistering and fingernail
dystrophy of the proband as well as the dental anomalies of the father are also shown.
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sequence analysis demonstrated that the parents were
heterozygous. Patients 3 and 4 (Fig 1C) were compound
heterozygous for the same c.1834G4A transition as patient
2 and for a duplication in exon 52, c.3800dupC, which
causes a frameshift, a PTC, and non–sense-mediated RNA
decay, as indicated by RT-PCR with total RNA extracted
from keratinocytes of patient 3. The mother was het-
erozygous for c.1834G4A and the father for c.3800dupC.
Patient 5 (Fig 1D) had a homozygous splice site mutation
c.2336-2A4G, which results in an in-frame skipping of the
entire exon 32 (Chavanas et al, 1997). This leads to deletion
of the amino acids 779–787 (D779–787). The mutation
c.2336–2A4G eliminated the restriction site for PstI, and
endonuclease digestions verified the patient to be ho-
mozygous and both parents to be heterozygous for this
mutation.
Glycine substitution mutations decrease the thermal
stability of the collagen XVII ectodomain The two novel
glycine substitutions, G609D and G612R, and G627V (McG-
rath et al, 1996) and G633D (Tasanen et al, 2000b), and
D779–787 were introduced into the expression vector cod-
ing for full-length collagen XVII (Franzke et al, 2004). The
mutated recombinant collagens were expressed transiently
in COS-7 cells, which have recently been found suitable for
studying collagen XVII synthesis and triple-helix formation
(Franzke et al, 2004). The transmembrane and shed forms
of collagen XVII were found in cell extracts and media, re-
spectively, indicating that the mutated variants were ex-
pressed and shed from the cell surface (data not shown).
After immunoprecipitation of the ectodomain, its triple-hel-
ical structure and thermal stability were assessed using
limited trypsin digestion as probe. Similar brief protease di-
gestions have been previously used to assay the effects of
glycine substitutions on the thermal stability of a-chains
of other collagen types (Tromp et al, 1989; see Prockop, 1990;
Byers, 2001 and references therein). Both wild-type and
mutated shed ectodomains of collagen XVII (120 kDa) were
degraded into trypsin-resistant intermediates of 90 kDa at
41C already, but in further digestions, the intermediate frag-
ments lost their stabilities at different temperatures (Fig 2).
The 90 kDa fragment was recognized by the NC16A anti-
body (Fig 2), indicating that the Col15 domain, located C-
terminally to the NC16A domain and, at least, a part of the
NC16A domain, were present in the intermediate fragment.
The mutated ectodomains with the glycine substitutions
G609D and G612D started to unfold at 241C and lost their
stability to 50% at 281C. The mutated ectodomains with
G627V and G633D started to unfold at 221C and lost their
stability to 50% at 241C. Thus, the glycine substitution mu-
tations destabilized significantly the ectodomain of collagen
XVII. In contrast, the melting ranges of the wild-type ecto-
domain, the deletion mutant D779–787, and the ectodomain
with valine substitution V703M were very similar (Fig 2).
These results indicate that the deletion of nine amino acids,
or three Gly–X–Y triplets, and the substitution of another
amino acid than glycine had no effect on the thermal sta-
bility of the collagen XVII ectodomain.
Structural predictions of the consequences of Gly sub-
stitutions The substitution of the smallest amino acid,
glycine, with other amino acids within a collagenous se-
quence can interfere with its triple-helical structure, leading
to a disturbed, non-functional collagen molecule. Similarly,
sequence alterations within the collagenous domain caused
by deletions or insertions of amino acids can disrupt its
typical Gly–X–Y triplet sequence and damage the triple-
helical tertiary structure. The conformational consequences
of the glycine substitutions and D779–787 were analyzed
using secondary structure prediction computer programs
PSAAM (University of Illinois), the PredictProtein Server
(CUBIC, Biochemistry, Columbia University, New York), and
the Ambivalent Structure Predictor (Young et al, 1999), in
combination with the program SEG (Wootton and Federhen,
1996), which divides sequences into low-complexity (‘‘sim-
ple’’) and high-complexity segments that can be used for
the identification of specific structural alterations within the
protein sequence.
The collagen XVII stretch selected for analysis spanned
the amino acid residues 490–810, which contain the
NC16A, the Col15, and the NC15 domains. Wild-type col-
lagen XVII was predicted to have three major a-helical el-
ements in the NC16A domain, an all-over loop (random coil)
formed by the Col15 domain, representing the collagenous
domain, and the NC15 domain with a short b-sheet portion
(Fig 3). The structure predictions of G609D and G612R re-
vealed one disruption of the all-over Col15 loop structure
Figure2
Trypsin digestions of recombinant wild-type and mutated ectodo-
mains. The immunoprecipitated shed ectodomain was treated with
trypsin for 2 min at incremental temperatures between 41C and 501C.
Quantitation of the immunoblot signals obtained with the NC16A an-
tibody showed that the treatment first resulted in a 90 kDa intermediate
digestion product, whose stability was reduced by substituting the Gly
residue at the positions 609, 612, 627, or 633. The wild-type ectodo-
main lost its stability by about 50% at 441C. The ectodomains with the
glycine substitutions G609D or G612R lost about 50% of their stability
at 281C, whereas the substitutions G627D or G633D resulted in a Tm of
241C. The deletion of the amino acids 779–787 (D779–787) and the
substitution V703M had no detectable effect on the thermal stability of
the ectodomain. (U, undigested sample).
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in close proximity to the mutated amino acid, which was
internally confirmed by the occurrence of new high-com-
plexity regions in the same areas. In contrast, the structure
predictions of G627V and G633D showed more severe
structural changes within the Col15 domain. Both predic-
tions exhibited four disruptions, which were highly similar,
within the loop structure and larger part of a new generated
high-complexity region around the mutated amino acid. In
addition, structural changes also occurred in the NC16A
domain. The structural prediction of D779–787 results in
four disruptions of the all-over Col15 loop and the gener-
ation of a small new high-complexity region situated C-ter-
minally of the deletion. In this case, additional structural
changes were also predicted in both the NC16A and the
NC15 domain (Fig 3).
Discussion
Mutations in the fibrillar collagen types I, II, III, IX, X, and XI
cause a wide spectrum of diseases such as osteogenesis
imperfecta, some subtypes of Ehlers–Danlos syndrome,
and a variety of chondrodysplasias. In these collagens,
substitutions for glycine residues in the triple-helical do-
mains are among the most common effects of mutations,
and the substituting residue and its location in the chain
contribute to the effect on folding and also on the pheno-
type (Prockop, 1990; Kuivaniemi et al, 1997; Byers, 2001;
Persikov et al, 2004). Glycine substitutions in dystrophic
epidermolysis bullosa are located within the triple helix of
the type VII collagen gene COL7A1 and disturb protein
folding by dominant-negative interference (Bruckner-Tuder-
man, 2002; Mallipeddi et al, 2003). In the group of trans-
membrane collagens, mutations resulting in glycine
substitutions have been detected in the human COL17A1
gene and the human EDA-1 (ectodysplasin A) gene (see
Franzke et al, 2005). In COL17A1, mutations leading to
glycine substitutions are rare, and all the known glycine
substitutions affect sequences in the largest collagenous
domain, Col15, of collagen XVII (see Table I).
These data indicate that the Col15 domain, which con-
tains 232 amino acids (amino acids 567–808), contributes
significantly to the stability of the collagen XVII homotrimer.
We have previously shown that this domain alone, when
expressed as a eukaryotic recombinant fragment, formed
a triple helix with a Tm of 26.51C (Tasanen et al, 2000a). A
longer fragment of 281 amino acids, which contained both
Col15 and the adjacent 49 amino acids of the NC16A
Figure 3
Structural predictions of the extracellular juxtamembranous part of the wild-type and mutated collagen XVII (amino acids 490–810).
Secondary protein structure prediction based on the amino acid sequence and the comparison of known protein structures with similar amino acid
sequences was performed as described in Results. The collagen XVII stretch (amino acids 490–810) including the NC16A, the Col15, and the NC15
domains was analyzed for wild-type collagen XVII and the mutants. The amino acids are shown in a single-letter code, the magenta characters
represent the NC16A and NC15 domains, and the black characters stand for the Col15 domain. The lower row indicates the secondary structure
predictions a-helix (red boxed H), b-sheet (blue boxed E), and loop (green boxed L) with an expected average accuracy of482%. For residues with
secondary structure predictions of lower confidence, no prediction was made, and a dot (.) was used instead. Differences in the distribution of high-
complexity regions within the amino acid sequence of the wild-type collagen XVII and the mutated forms are indicated with #. The prediction of the
wild-type collagen XVII showed three major a-helical elements in the NC16A domain, an all-over loop formed Col15 domain, representing the
collagenous triple helices, and the NC15 domain with a slight b-sheet portion.
GLYCINE SUBSTITUTIONS IN COLLAGEN XVII 1115125 : 6 DECEMBER 2005
domain, formed a triple helix with a melting temperature of
351C (Areida et al, 2001). This difference is feasible, as the
NC16A domain contains coiled–coiled structures, which are
likely to serve as a nucleus for trimerization and subsequent
triple-helix formation (Areida et al, 2001). Our recent studies
indicated that recombinantly expressed full-length collagen
XVII forms a stable triple-helix, with a Tm of 431C, and that
the shed ectodomain serves as a suitable model for studies
on protein conformation and stability (Franzke et al, 2004).
The above observations demonstrate that similar to other
collagens, the triple-helix stability of transmembrane colla-
gen XVII depends on the total length of the collagenous
domain. For this reason, we opted to engineer mutations
into the full-length collagen XVII. This approach allowed us
to perform conformational analyses on stable recombinant
proteins and to avoid putative complications because of
the relative conformational instability of short collagenous
fragments.
Another evidence of the importance of the Col15 domain
for the stability of the collagen XVII comes from mutation
studies. Two previously described glycine substitution mu-
tations, G627V (McGrath et al, 1996; Table I, patient 6) and
G633D (Tasanen et al, 2000b; Table I, patient 7), occurred in
combination with null alleles in compound heterozygous
patients. Therefore, they were functionally homozygous and
resulted in the production of homotrimeric mutated collagen
XVII molecules in vivo. The hypothesis is that the mutations
may lead to inhibition of physiological ligand binding or
proteolytic degradation of the mutant protein and to skin
blistering. When these glycine substitutions were generated
into a recombinantly expressed Col15 or full-length ecto-
domain, the thermal stability of the Col15 domain was sig-
nificantly decreased (Olague-Marchan et al, 2000; Tasanen
et al, 2000a, b).
Also, the two novel glycine substitutions of this study,
G609D and G612R, occurred either in a homozygous state
(patient 2) or in combination with a PTC (patients 1, 3, and
4). Thus, all carriers known so far are either homozygous or
functionally hemizygous for glycine substitutions. This al-
lowed us to utilize homotrimers of the mutated recombinant
collagen XVII to study the molecular abnormalities related to
these mutations. An examination of the four recombinants
with glycine substitutions showed their thermal stability to
be significantly reduced, whereas the valine substitution
V703M had no effect on the Tm of the ectodomain. The
glycine susbtitutions located more aminoterminally, G609D
and G612R, reduced Tm slightly less than the mutations
G627V and G633D, which are situated more centrally in the
Col15 domain. These results are in good accordance with
the secondary structure predictions, which revealed that
G609D and G612R caused only one interception within the
Col15 domain, but no variances in the non-collagenous
domains NC16A and NC15, whereas G627V and G633D
resulted in four disruptions within the Col15 loop structure
and additional changes in NC16A domain. In accordance
with previous studies by us (Scha¨cke et al, 1998; Franzke
et al, 2004) and others (Areida et al, 2001), short protease
treatment of triple-helical collagen XVII led to its C-terminal
truncation, whereas at least part of the NC16A domain re-
mained uncleaved. Possible reasons of this cleavage pro-
tection may be because of the structural features of the
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ternary NC16A structure, which is influenced by the triple-
helical collagenous Col15 domain.
The consequences of the ‘‘in-register’’ deletion D779–
787 are particularly interesting. Unexpectedly, this had no
effect on thermal stability of its molecule. The structural
predictions indicated on the one hand changes similar to
those caused by G627V and G633D. On the other hand,
D779–787 caused additional structural variance within the
non-collagenous NC15 domain, i.e., formation of predom-
inantly all-over loop structure, instead of the b-sheet struc-
ture in the wild type (Fig 3). Therefore, it is likely that the
altered NC15 domain compensates deleterious effects in
the Col15 domain and thereby contributes to a normal ther-
mal stability. In this case, it seems feasible that the effects of
the deletion, which are observed in JEB, involve perturbed
ligand interactions rather than triple helix destabilization.
The mutations causing alterations in the Col15 domain of
collagen XVII, the clinical presentation of eight probands
and results from trypsin digestions and secondary structure
predictions are summarized in Table I. Compared with the
COL17A1 null mutations, the phenotypes associated with
the Col15 domain mutations are milder, with acral or gen-
eralized mild/moderate blistering of the skin, but without
major mucosal involvement. In three of the patients the
blistering of the skin was localized mainly to acral body
parts like hands and feet, which are usually more prone to
mechanical traumas than central parts of the body. Similar
to null mutations, all carriers of Col15 domain mutations had
nail dystrophy and dental abnormalities. Hair involvement
was observed in four patients, but only one proband had
total alopecia, which is typical of COL17A1 null mutations.
In summary, mutations affecting the Col15 domain are as-
sociated with milder phenotypic changes, but an unequiv-
ocal correlation between the type or localization of the
mutation and the clinical phenotype remains elusive. Fur-
ther analysis of mutations and their biological consequen-
ces are required to determine whether only COL17A1
mutations, or also putative modifying genes, are involved
in determination of the phenotype.
Materials and Methods
Patients
Patient 1 The 40-y-old male was earlier found to be compound
heterozygous for a c.3781C ! T transition designated as
p.R1226X (Floeth et al, 1998). At that time, the second mutation
was not found. The proband has had non-scarring, generalized,
trauma-induced skin blistering since birth, and in the course of the
disease, hyper- and hypopigmentation of skin and nail dystrophy
have developed (Fig 1A).
Patient 2 The newborn male is the second child of consanguin-
eous Turkish parents. The family history includes a great aunt with
skin blisters in childhood. The proband had blisters and erosions
on his hands and feet at birth and later also on his trunk and
ears. Electron microscopy revealed junctional blistering with intact
keratinocytes in the blister roof and normal lamina densa and
anchoring filaments in the blister base. Antigen mapping of
spontaneously blistered skin showed binding of antibodies to
cytokeratins, a6b4 integrin to the blister roof, and laminin 5 and
collagens IV and VII to the blister base. The stainings for collagen
XVII and plectin were reduced and fragmented. For antigen map-
ping, the rabbit anti-human collagen XVII antibody directed against
the NC16A domain (Schumann et al, 2000) and the monoclonal
mouse BP180/collagen XVII antibody MoAb 123 (kind gift from Dr
P. Marinkovich, Stanford) were used. The other antibodies for an-
tigen mapping were described elsewhere (Schumann et al, 2000).
Patients 3 and 4 Patient 3 is an 8-y-old girl, the youngest child of
healthy, non-consanguineous Finnish parents. She had rather se-
vere blistering at birth already. Generalized moderate blistering
continues, and she also has nail dystrophy, dental problems, poor-
ly healing wounds, and partial alopecia of the scalp (Fig 1C).
Immunohistochemical staining with basement membrane zone an-
tibodies showed junctional blistering with reduced collagen XVII
staining. Her 22-y-old brother, who is our patient 4, has had blisters
since the neonatal period. His disease is milder than his sister’s,
but he also has partial alopecia and tooth and nail dystrophy.
Based on clinical data and electron microscopic analysis in the
early 1980s, he was thought to have epidermolysis bullosa sim-
plex. Otherwise, the family history was negative for blistering skin
diseases. The parents have no dental anomalies.
Patient 5 The proband, a 4-y-old German female, is the third child
of non-consanguineous parents. The family history is negative for
skin diseases. Immediately after birth, she developed blisters on
hands. Blistering continued, especially on the extremities. She has
both nail and dental dystrophies, and her parents also have dental
anomalies (Fig 1D). Electron microscopy revealed junctional
blistering with intact keratinocytes in the blister roof and normal
lamina densa and anchoring filaments in the blister base.
Immunohistochemical staining with basement membrane zone an-
tibodies showed junctional blistering with negative collagen XVII
staining.
Mutation detection and RT-PCR The study was approved by the
ethical committee of the University of Freiburg and conducted ac-
cording to the declaration of Helsinki principles. After informed
consent, genomic DNA was isolated from the patients’ peripheral
blood using the QIAamp Blood Kit (Qiagen, Hilden, Germany). PCR
amplification of all COL17A1 exons and exon–intron boundaries
was performed as described by Gatalica et al (1997; Genbank Nr.
M91669); the primers used for the amplification of exons 21, 22,
and 32 are shown in Table S1. Purified PCR products were se-
quenced in both directions by using standard methods and an
ABI310 sequencer (Applied Biosystems, Foster City, California).
The nucleotide positions of the detected mutations were numbered
by setting the first nucleotide of the starting methionine codon as 1.
To verify if the mutation c.1834G4A disturbs the normal splice site,
total RNA was extracted from the keratinocytes of patient 3 and
RT-PCR for exons 17–23 was performed using primers shown in
Table S1. Excepting the mentioned mutations, some other se-
quence variants were found in the patients, all of them being
known polymorphisms (www.ncbi.nlm.nih.gov/SNP/) like the G4A
transition at nucleotide position 2212 resulting in p.V703M in the
middle of Col15 domain (Schumann et al, 1997). The other clinically
observed Col15 domain substitutions and deletions were obtained
from the online mutation databases (Human Gene Mutation Data-
base; www.hgmd.org) for the COL17A1 gene in December 2004.
Generation, expression, and analysis of recombinant mutated
collagen XVII The glycine substitution mutations G612R, G627V,
and G633D, and the deletion of the amino acids 779–787 were
accomplished to the full-length human collagen XVII cDNA (Gen-
Bank accession number M911669, see Franzke et al, 2004) by
using the QuikChange Site-Directed Mutagenesis kit (Stratagene
Europe, Amsterdam, the Netherlands) and the sense and antisense
primers containing the desired mutations shown in Table S2. The
G609D and V703M (Schumann et al, 1997) were generated by
using The GeneTailor Site-Directed Mutagenesis System (InVitro-
gen Europe, Leek, the Netherlands) and the overlapping primers
shown in Table S2. The generation of the desired point mutations
and the deletion were confirmed by DNA sequencing.
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The wild-type and mutated constructs were expressed in COS-
7 cells in the presence of 50 mg per mL ascorbic acid as described
earlier (Franzke et al, 2004). After immunoprecipitations of cell
culture medium, the triple-helical conformation of the ectodomains
was tested using trypsin as probe (see Franzke et al, 2004). After
immunoblotting with the NC16A antibody (Schumann et al, 2000),
the scanning and the quantitation of the digestion products
were performed by Quantity One software (Bio-Rad, Hercules,
California).
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